Lie Deng | Oncology | Outstanding Contribution Award

Mr.  Lie Deng | Oncology | Outstanding Contribution Award

Foshan institution of pathogenic microorganism | China

This academic summary highlights advanced expertise in medical research design, Oncology statistical analysis, biochemical and molecular biology techniques, cell culture methodologies, and bioinformatics, with a strong focus on respiratory syncytial virus research. The work emphasizes the development and optimization of molecular and immunological assays to support vaccine evaluation and translational research. Robust reverse transcription quantitative polymerase chain reaction and antibody enzyme linked immunosorbent assay methods were established to assess viral load and immune responses, providing reliable alternatives to commercially available detection systems while improving laboratory efficiency and accessibility. Comprehensive research efforts also include critical analysis of global vaccine development strategies, encompassing diverse technical routes such as live attenuated vaccines, subunit vaccines, vector based platforms, and nucleic acid approaches. These contributions integrate experimental data with comparative evaluation frameworks, offering valuable insights into vaccine design, efficacy assessment, and methodological standardization. In addition, the preparation of detailed molecular biology operation guidelines strengthened laboratory practices and ensured reproducibility of experimental workflows. Training activities focused on molecular cloning, polymerase chain reaction based assays, and data validation principles, supporting the development of independent experimental competence and high quality data generation. Overall, this body of work demonstrates a strong integration of experimental innovation, methodological rigor, and knowledge dissemination, contributing meaningfully to vaccine research, laboratory capacity building, and the advancement of evidence based evaluation methods in virology and immunological studies.

Profile: ORCID

Featured Publications 

Deng, L., Cao, H., Li, G., Zhou, K., Fu, Z., Zhong, J., Wang, Z., & Yang, X. (2025). Progress on respiratory syncytial virus vaccine development and evaluation methods. Vaccines, 13(3), 304.

Dr. Takeshi Yoshimoto – Cancer – Best Researcher Award

Dr. Takeshi Yoshimoto - Cancer - Best Researcher Award

University of Tsukuba Hospital - Japan

Author Profile

SCOPUS

🎓 Early academic pursuits

 Dr. Takeshi Yoshimoto began his academic journey in the medical sciences with a strong foundation in clinical education. he earned his m.d. from hiroshima university faculty of medicine in march 2008, followed by a ph.d. from the graduate school of biomedical and health sciences, hiroshima university in august 2022. during his formative years, his curiosity about cerebrovascular diseases led him to explore genetics, biomarkers, and translational medicine, laying the groundwork for his future research focus, which indirectly intersects with diagnostic technologies resembling the precision systems used in power electronics.

🧠 Professional endeavors

Dr. Yoshimoto's career showcases a rich progression through esteemed institutions. from his early role as an intern at fukushima coop hospital, he gradually ascended through ranks at national cerebral and cardiovascular center, serving as resident, senior resident, Cancer and later as a medical doctor under  distinguished mentors like dr. ihara and dr. toyoda. he also contributed to academia at hiroshima university and currently serves as a lecturer in the department of stroke and cerebrovascular diseases at university of tsukuba hospital. his consistent clinical involvement paired with academic appointments underlines his dual commitment to patient care and neurological research.

🧬 Contributions and research focus

A pioneer in translational stroke research, dr. yoshimoto focuses on integrating genetics with acute stroke management. his primary research involves developing algorithms for selecting clot removal devices by identifying genetic variations, particularly the moyamoya-related rnf213 p.r4810k polymorphism. he explores the association between juvenile strokes and serum biomarkers. his projects are comparable in Cancer precision and application-oriented design to power electronics, highlighting his innovative integration of medical diagnostics and genetic profiling to improve acute care strategies.

🌍 Impact and influence

Dr. Yoshimoto’s work has had significant impact on cerebrovascular research, especially in japan. his dedication to exploring the genetic underpinnings of stroke has advanced understanding of moyamoya disease and enhanced patient stratification for endovascular therapy. his influence is also evident in the repeated recognition he received at prestigious national and international conferences, positioning him as a leading voice Cancer in neurovascular translational research. the framework he established for genetic-based intervention selection has potential parallels with feedback and adaptive systems in power electronics, reflecting the precision and personalization he brings to neurology.

🏆 Academic cites and recognition

Dr. Yoshimoto’s excellence has been widely acknowledged. he received the paul dudley white international scholar award from the american heart association in 2021 and multiple presentation awards at the japan stroke society and japanese society of neuroendovascular therapy (jsnet). notably, he received teaching awards and outstanding paper honors, reinforcing his role Cancer as both a scholar and mentor. these accolades validate the academic rigor and practical relevance of his work, particularly his contributions to stroke genetics and device selection.

🔬 Legacy and future contributions

Dr. Yoshimoto is poised to continue shaping the future of stroke research with a strong emphasis on personalized medicine. he aims to refine and implement his clot removal device selection algorithm into broader clinical practice. further integration of genetic biomarkers into real-time therapeutic decision-making is expected. his work not only improves outcomes for stroke patients but also sets a model for interdisciplinary research convergence, similar to how power electronics evolved by merging physics, control theory, and electrical engineering.

Notable Publication

  • Title: Relationship Between RNF213 p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study
    Author(s): Kotaro Noda, Yorito Hattori, Tatsuya Nishii, Yoshikazu Nakaoka, Masafumi Ihara
    Journal: Journal of the American Heart Association, 2025

  • Title: Deep learning-based post hoc denoising for 3D volume-rendered cardiac CT in mitral valve prolapse
    Author(s): Tatsuya Nishii, Tomoro Morikawa, Hiroki Nakajima, Satsuki M. Fukushima, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2025

  • Title: Evaluation of the Efficacy and Accuracy of Super-Flexible Three-Dimensional Heart Models of Congenital Heart Disease Made via Stereolithography Printing and Vacuum Casting: A Multicenter Clinical Trial
    Author(s): Isao Shiraishi, Masaaki Yamagishi, Takaya Hoashi, Toshiaki Hisada, Kenichi Kurosaki
    Journal: Journal of Cardiovascular Development and Disease, 2024

  • Title: Pericardial adhesion and performance of hemodynamically significant constrictive pericarditis using cine magnetic resonance feature tracking
    Author(s): Yasutoshi Ohta, Midori Fukuyama, Yoshiaki Morita, Hiroki Horinouchi, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2024

  • Title: Laterality of CT-measured hepatic extracellular volume fraction in patients with chronic thromboembolic pulmonary hypertension
    Author(s): Tatsuya Nishii, Hiroki Horinouchi, Takara Namboku, Takeshi Ogo, Tetsuya Fukuda
    Journal: International Journal of Cardiovascular Imaging, 2024

  • Title: Covering the intercostal artery branching of the Adamkiewicz artery during endovascular aortic repair increases the risk of spinal cord ischemia
    Author(s): Yoshimasa Seike, Tatsuya Nishii, Kazufumi Yoshida, Tetsuya Fukuda, Hitoshi Matsuda
    Journal: JTCVS Open, 2024